I. Mechanism

  1. Conjugated protein Vaccine

II. Preparations

  1. HIBTITER (HbOC)
  2. PedvaxHIB (PRP-OMP)
  3. ActHIB (PRP-T)

III. Primary Series

  1. Dose 1: Age 2 months
  2. Dose 2: Age 4 months
  3. Dose 3: Age 6 months
  4. Dose 4: Age 12 to 15 months

IV. Adverse Effects

  1. No serious side effects
  2. References
    1. (1996) MMWR Morb Mortal Wkly Rep 45(No. RR-12):1-35

Images: Related links to external sites (from Google)

Ontology: Haemophilus influenzae type b polysaccharide vaccine (C0062086)

Concepts Pharmacologic Substance (T121) , Immunologic Factor(T129)
MSH C044237
SnomedCT 333680004, 412374001
English Haemophilus influenzae type b polysaccharide vaccine, HIB-vaccine, HIB - Hemophilus influenzae Type B vaccine, HIB vaccine, Haemophilus influenzae Type b, Hemophilus influenzae Type b, Hemophilus influenzae Type b vaccine, Haemophilus influenzae type B vaccine, Haemophilus influenzae type b polyribosylribitol phosphate capsular polysaccharide vaccine, Hemophilus influenzae type b vaccine, hib vaccine, Haemophilus influenzae Type b vaccine (product), Haemophilus influenzae Type b vaccine (substance), Haemophilus influenzae type b vaccine (substance), Haemophilus influenzae type b vaccine, HIB - Haemophilus influenzae Type B vaccine, Haemophilus influenzae Type b vaccine
Spanish vacuna anti-Haemophilus influenzae tipo b (producto), vacuna anti-Haemophilus influenzae tipo b, vacuna anti-Haemophilus influenzae tipo b (sustancia)